Conference abstract · 2 Nov 2017
Conference abstractPublished 17 Jul 2017
Emap II-Induced Immune Suppression In Colorectal Cancer
Minia University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Colorectal cancer (CRC) is being currently considered one of the most common, and deadly, malignancies in the world. Many CRC patients are likely to be immunosuppressive. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional cytokine with pro-inflammatory properties. It was demonstrated that EMAP-II induces lymphocytes apoptosis in CRC. The purpose of this study is to investigate the role of EMAP II in immune suppression in CRC. Methodology & Theoretical Orientation: The immunosuppressive effect of EMAP II was verified by in vivo and in vitro experiments. The immunosuppressive mechanisms were analysed using flow cytometry, ELISA, immunohistochemistry, and T-lymphocytes assays. Findings: EMAP II expression in CRC was associated with suppression of T cell activity and decreased infiltrating T cells. EMAP II blockade in mice bearing colorectal cancer reduced tumour burden and increased T cell responses. In this study, we found that colorectal cancer-infiltrating tregs expressed increased levels of EMAP II. Furthermore, EMAP-II levels correlated positively with serum IL-2 and TGF-β (p<0.001). Conclusion & Significance: This study has demonstrated the role of EMAP II in immune suppression and the potential for immunotherapy via blocking EMAP II in CRC.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2 Aug 2018
Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells
Conference abstract · 19 Oct 2017
Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway
Short communication · 29 Feb 2024
Leveraging the Immune System for Metastasis Suppression: A Promising Frontier in Cancer Therapy.
Conference abstract · 21 Nov 2022
Cancer-associated Fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells though exosome derived ACSL4 -targeting miRNAS
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGastroenterology & Hepatology
- SubjectImmunology & Microbiology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Manal Mohamed Saber”
